DEATH RECEPTOR SENSITIZING COMPOUNDS AND METHODS OF USE THEREFOR
申请人:Schimmer Aaron D.
公开号:US20080166378A1
公开(公告)日:2008-07-10
Methods of identifying death receptor sensitizing compounds and methods of using death receptor sensitizing compounds are provided.
Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
申请人:Reed John C.
公开号:US20080206287A1
公开(公告)日:2008-08-28
Cyclosporin A has been discovered to sensitize cancers resistant to TNF-family death receptors such as TRAIL and Fas to ligand-mediated apoptosis. Therefore, compositions that include cyclosporin A are useful in treating such cancers.
US8008354B2
申请人:——
公开号:US8008354B2
公开(公告)日:2011-08-30
[EN] USE OF CYCLOSPORIN A TO SENSITIZE RESISTANT CANCER CELLS TO DEATH RECEPTOR LIGANDS<br/>[FR] UTILISATION DE CYCLOSPORINE A POUR SENSIBILISER DES CELLULES CANCÉREUSES RÉSISTANTES À DES LIGANDS DE RÉCEPTEUR DE MORT
申请人:BURHAM INST FOR MEDICAL RES
公开号:WO2008036244A1
公开(公告)日:2008-03-27
[EN] Cyclosporin A has been discovered to sensitize cancers resistant to TNF-family death receptors such as TRAIL and Fas to ligand-mediated apoptosis. Therefore, compositions that include cyclosporin A are useful in treating such cancers. [FR] Des recherches ont montré que la cyclosporine A sensibilise les cancers résistants aux récepteurs de mort de la famille du TNF, de type TRAIL et Fas à l'apoptose dont la médiation est assurée par des ligands. L'invention propose ainsi des compositions qui comprennent de la cyclosporine A utiles dans le traitement desdits cancers.